IHS Chemical Week

World News and Views :: Top of the News

Lonza signs manufacturing deal with US biotech firm

12:08 AM MDT | October 2, 2012 | Deepti Ramesh

Lonza says it has entered into a process transfer and manufacturing agreement with Celladon Corp. (San Diego, CA), a privately held biotechnology company focused on the discovery and development of treatments for cardiovascular diseases. Lonza, under the terms of the agreement, will manufacture cGMP-grade Mydicar, Celladon’s product candidate for the treatment of advanced heart failure, for use in future clinical trials. In the event Celladon intends to commence commercial scale manufacture of Mydicar, Celladon and Lonza have agreed to negotiate a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa